stella
beta
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer — Stella
Recruiting
Back to Ovarian Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Moffitt Cancer Center, Tampa, Florida
View full record on ClinicalTrials.gov